Rating Change
JP Morgan reiterated its Overweight rating on Oculis Holding AG (NASDAQ:OCS) on August 14, 2026.
JP Morgan reiterated its Overweight rating on Oculis Holding AG (NASDAQ:OCS) on August 14, 2026.

At publication ·
Oculis Holding AG (NASDAQ:OCS) · reiterate
At a glance
JP Morgan reiterated its Overweight rating on Oculis Holding AG (NASDAQ:OCS) on August 14, 2026.
Oculis Holding AG operates in the Healthcare sector. The stock currently trades at $12.94 with a market capitalization of $1.1B. The stock has declined 28.3% over the past 52 weeks.
Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Oculis Holding AG.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 14, 2026 | JP Morgan | Overweight | N/A |
| Aug 05, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jun 03, 2026 | JP Morgan | Overweight | N/A |
| Jun 02, 2026 | Baird | Outperform | N/A |
| Jun 01, 2026 | Stifel | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View OCS Stock Page
A rating of Overweight from JP Morgan reflects the analyst's outlook on Oculis Holding AG (NASDAQ:OCS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the OCS forecast page.
Current market data
NASDAQ · OCS
$12.43
Down: -$0.54 · -4.16%
Live quote updated
Keep reading